Epidemiology of Fatal Systemic Sclerosis (Diffuse Scleroderma)
Authors: ALFONSE T. MASI
Journal: Annals of Internal Medicine (1967)

Article1 May 1967Epidemiology of Fatal Systemic Sclerosis (Diffuse Scleroderma)A 15-Year Survey in BaltimoreALFONSE T. MASI, M.D., DR.P.H., F.A.C.P., WILLIAM A. D'ANGELO, M.D.ALFONSE T. MASI, M.D., DR.P.H., F.A.C.P.Search for more papers by this author, WILLIAM A. D'ANGELO, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-66-5-870 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptLittle is known about the factors that predispose to systemic sclerosis (diffuse scleroderma) or that influence its usually progressive and fatal outcome. Epidemiologic studies, which relate cases to a defined community population, may reveal clues to personal, socioeconomic, or environmental determinants in this disease of unknown cause. A community-wide survey, furthermore, promises a larger and more representative sample of cases than might be found at a single institution. This improved sample of patients offers a better opportunity to define the characteristics and natural history of the disease.No previous population study of systemic sclerosis has been reported, and this paper...References1. RODNANFENNELL GPRH: Progressive systemic sclerosis sine scleroderma. JAMA 180: 665, 1962. CrossrefMedlineGoogle Scholar2. Computation of rates and indices, in Handbook of Vital Statistics Methods: Studies in Methods . . . Series F. No. 7, United Nations Publication no. 1955, XVII-I. Statistical Office of the United Nations, New York, 1955. Google Scholar3. MASISARTWELLSHULMAN ATPELE: The use of record linkage to determine familial occurrence of disease from hospital records (Hashimoto's disease). Amer. J. Public Health 54: 1887, 1964. CrossrefGoogle Scholar4. SIEGELLEEWIDELOCKREILLYWISEZINGALEFUERST MSLDEBGJSBHT: The epidemiology of systemic lupus erythematosus: preliminary results in New York City. J. Chronic Dis. 15: 131, 1962. CrossrefMedlineGoogle Scholar5. ERASMUS LD: Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonary manifestations. S. Afr. J. Lab. Clin. Med. 3: 209, 1957. MedlineGoogle Scholar6. RODNANCAMMARATA GPRJ: The association of progressive systemic sclerosis (diffuse scleroderma) with coal-miner's and other forms of pneumoconiosis (abstract). Arthritis Rheum. 6: 294, 1963. Google Scholar7. GRECOPELLEGRINIDUSIDAROLD SPUA: The association of pulmonary silicosis with scleroderma (a clinico-anatomical study). Med. Lavoro 55: 537, 1964. Google Scholar8. MYERS RJ: Limitations in the use of OASDI records for health studies. Amer. J. Public Health 55: 1787, 1965. CrossrefGoogle Scholar9. DUNCANDUNCAN ODB: Residential distribution and occupational stratification. Amer. J. Sociol. 60: 493, 1955. CrossrefGoogle Scholar10. ORABONAALBANO MLO: Progressive systemic sclerosis (or visceral scleroderma)—review of literature and report of cases. Acta Med. Scand. 160 (suppl. 333): 137, 1958. Google Scholar11. MCANDREWBARNES GMEG: Familial scleroderma. Ann. Phys. Med. 8: 128, 1965. MedlineGoogle Scholar12. BLANCHARDSPEED REEM: Scleroderma: periodontal membrane manifestations in two brothers. Periodontics 3: 77, 1965. MedlineGoogle Scholar13. RODNAN GP: A review of recent observations and current theories on the etiology and pathogenesis of progressive systemic sclerosis (diffuse scleroderma). J. Chronic Dis. 16: 929, 1963. CrossrefMedlineGoogle Scholar14. MASI AT: Potential uses and limitations of hospital data in epidemiologic research. Amer. J. Public Health 55: 658, 1965. CrossrefGoogle Scholar15. LEINWANDDURYEERICHTER IAWMN: Scleroderma (based on a study of over 150 cases). Ann. Intern. Med. 41: 1003, 1954. LinkGoogle Scholar16. RODNAN GP: Progressive systemic sclerosis (diffuse scleroderma), in Immunological Diseases, edited by SAMTER, M., ALEXANDER, H. L. Little, Brown and Co., Boston, 1965, chap. 69. Google Scholar17. TUFFANELLIWINKELMANN DLRK: Systemic scleroderma. A clinical study of 727 cases. Arch. Derm. (Chicago) 84: 359, 1961. CrossrefMedlineGoogle Scholar18. RODNAN GP: The natural history of progressive systemic sclerosis (diffuse scleroderma). Bull. Rheum. Dis. 13: 301, 1963. MedlineGoogle Scholar19. BIANCHIBISTUEWENDTPUROKEECH FAARVEHEMK: Analysis of twenty-seven cases of progressive systemic sclerosis (including two with combined systemic lupus erythematosus) and a review of the literature. J. Chronic Dis. 19: 953, 1966. CrossrefMedlineGoogle Scholar20. KLEMPERERPOLLACKBAEHR PADG: Diffuse collagen disease: acute disseminated lupus erythematosus and diffuse scleroderma. JAMA 119: 331, 1942. CrossrefGoogle Scholar21. FARMERGIFFORDHINES RGRWEA: Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases. Circulation 21: 1088, 1960. CrossrefMedlineGoogle Scholar22. KASSHANSONPATRICK HVJ: Scleroderma in childhood. J. Pediat. 68: 243, 1966. CrossrefGoogle Scholar23. MALLOY JF: Personal communication. Google Scholar24. MERRELLSHULMAN MLE: Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J. Chronic Dis. 1: 12, 1955. CrossrefMedlineGoogle Scholar25. DUBOISTUFFANELLI ELDL: Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190: 104, 1964. CrossrefMedlineGoogle Scholar26. RODNANBENEDEKMEDSGERCAMMARATA GPTGTARJ: The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann. Intern. Med. 66: 323, 1967. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ALFONSE T. MASI, M.D., DR.P.H., F.A.C.P.; WILLIAM A. D'ANGELO, M.D.Affiliations: Baltimore, Maryland, and Jersey City, New JerseyFrom the Department of Epidemiology, Johns Hopkins School of Hygiene, and the Connective Tissue Division, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Md.This study was supported in part by research grant AM-6726-03, the U. S. Public Health Service, Washington, D. C.At the time of this study Dr. Masi was the recipient of special fellowships 5F3 AM 21, 397-02 and 2F3, AM 21, 397-03, U. S. Public Health Service, Washington, D. C.Requests for reprints should be addressed to Alfonse T. Masi, M.D., Department of Epidemiology, The Johns Hopkins School of Hygiene, Baltimore, Md. 21205. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAfrican Americans and Scleroderma: Examining the Root Cause of the AssociationEvidence of selection as a cause for racial disparities in fibroproliferative diseasePredictors of inpatient mortality in patients with systemic sclerosis: a case control studyPleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative DiseasesMortality and survival in systemic sclerosis: Systematic review and meta-analysisRace and Association With Disease Manifestations and Mortality in SclerodermaEcho Doppler Predictors of Pulmonary Artery Hypertension in Patients with Systemic SclerosisEchocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosisEthnicity and race and systemic sclerosis: How it affects susceptibility, severity, antibody genetics, and clinical manifestationsGeographical variation in mortality from systemic lupus erythematosus in the United StatesSystemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinantsAutoimmune diseases: a leading cause of death among young and middle-aged women in the United StatesAtteinte de l'intestin grêle au cours de la sclérodermie systémiqueSystemic sclerosis prevalence and mortality in Sydney 1974-88Lymphoma and systemic sclerosis - an uncommon association or possible coincidence of two disorders with a fatal outcomeRacial differences in scleroderma among women in MichiganSCLERODERMA AND RELATED CONDITIONSPrevalence of Scleroderma Spectrum Disorders in the General Population of EstoniaEpidemiology of systemic sclerosisLong-term follow-up study of 164 patients with definite systemic sclerosis: Classification considerationsEpidemiology of scleroderma.Epidemiological study of patients with systemic sclerosis in TokyoPredictors of survival in systemic sclerosis (Scleroderma)Genetic control of avian sclerodermaEpidemiology and Natural History of Systemic SclerosisPrevalence of scleroderma spectrum disorders in the general population of south carolinaARTICLE: Paget's Disease of the Breast with Underlying Carcinoma Arising in Systemic SclerodermaThe lungs in systemic sclerosis (scleroderma): A review and new informationConnective tissue responses in blacks in relation to disease: Further observationsFibrosarcoma in a patient with sclerodermaEinteilung und Klinik der progressiven systemischen SklerodermieGenetik der SklerodermienRheumatologic Manifestations of CancerMortality from polymyositis and dermatomyositis in the united states, 1968–1978The immunopathology of progressive systemic sclerosis (PSS)Musculoskeletal syndromes associated with malignancyMedical geography and the aetiology of the rare connective tissue diseases in New ZealandBlack and white human skin differencesEpidemiology of Progressive Systemic SclerosisThe epidemiology of systemic sclerosis (scleroderma) among male U.S. veteransStudies of Idiopathic Intestinal PseudoobstructionStudies of Idiopathic Intestinal PseudoobstructionProgressive systemic sclerosis in a familyIdiopathic Pulmonary Fibrosis Clinical, Histologic, Radiographic, Physiologic, Scintigraphic, Cytologic, and Biochemical AspectsRONALD G. CRYSTAL, M.D., JACK D. FULMER, M.D., WILLIAM C. ROBERTS, M.D., MORTON L. MOSS, M.D., BRUCE R. LINE, M.D., HERBERT Y. REYNOLDS, M.D., F.A.C.P.Roentgenographic changes in the arthritidesPathogenesis of systemic sclerosis: A vascular hypothesisScleroderma in the childConnective tissue responses in Negroes in relation to diseaseOccupational Trauma, Raynaud Phenomenon, and SclerodactyliaMotor Disorders Due to Collagen DiseasesMotor Disorders Due to Collagen DiseasesSurvival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patientsThe epidemiology of systemic lupus erythematosusGENERALIZED SCLERODERMASurvival with Systemic Sclerosis (Scleroderma) A Life-Table Analysis of Clinical and Demographic Factors in 309 PatientsTHOMAS A. MEDSGER JR., M.D., ALFONSE T. MASI, M.D., Dr. P.H., F.A.C.P., GERALD P. RODNAN, M.D., F.A.C.P., THOMAS G. BENEDEK, M.D., F.A.C.P., HARRY ROBINSON, D.Sc.Epidemiology of Systemic Sclerosis (Scleroderma)THOMAS A. MEDSGER JR., M.D., ALFONSE T. MASI, M.D., Dr. P.H., F.A.C.P.Factors Affecting Survivorship in Polymyositis. A Life-Table Study of 124 PatientsNineteenth rheumatism review. Part-IIIThe epidemiology of polymyositisPathologic observations in systemic sclerosis (scleroderma)Cancer and arthritis 1 May 1967Volume 66, Issue 5Page: 870-883KeywordsConnective tissueEpidemiologyFellowshipsGratitudeHygieneMedical servicesNatural history of diseaseResearch grantsScleroderma ePublished: 1 December 2008 Issue Published: 1 May 1967 PDF downloadLoading ...